Hemofarm is the leader on the pharmaceutical market of Serbia. Taking up over 70% of the total exports of pharmaceutical products, the Vršac-based company is at the same time the largest Serbian exporter of drugs. Hemofarm manufactures about 5.5 billion tablets and capsules annually. It operates on three continents and it has a team of over 3,000 employees. In addition to being present on 36 markets around the World, Hemofarm is among the largest pharmaceutical manufacturers in this region.

The company is committed to permanent innovation. In addition to researching and developing modern pharmaceutical products, Hemofarm pays special attention to sustainable operation, which is harmonised with the BSCI Code of Conduct in terms of social responsibility and respecting human rights. The BSCI compliance of 97.6% represents the best result among all the companies operating in Serbia.